 | • レポートコード：QY2203B01721 • 出版社/出版日：QYResearch / 2022年3月11日 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のインフルエンザ治療薬・ワクチン の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインフルエンザ治療薬・ワクチン の世界市場のxxx％を占める「インフルエンザ治療薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のインフルエンザ治療薬・ワクチン の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのインフルエンザ治療薬・ワクチン 市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのインフルエンザ治療薬・ワクチン 市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 インフルエンザ治療薬・ワクチン のグローバル主要メーカーには、Bristol Myers Squibb、AstraZeneca、Eli Lilly、Roche、GlaxoSmithKline、Novartis、Pfizer、Sanofi Pasteur、Bayer、Celgene、Seqirus、Protein Sciences Corporation、Serum Institute of India、Emergent Biosolutions、BioCryst Pharmaceuticals、Alvogenなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 インフルエンザ治療薬・ワクチン 市場は、種類と用途によって区分されます。世界のインフルエンザ治療薬・ワクチン 市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 インフルエンザ治療薬、インフルエンザワクチン 【用途別セグメント】 病院薬局、小売店薬局、オンライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - インフルエンザ治療薬・ワクチン 製品概要 - 種類別市場（インフルエンザ治療薬、インフルエンザワクチン） - 用途別市場（病院薬局、小売店薬局、オンライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界のインフルエンザ治療薬・ワクチン 販売量予測2017-2028 - 世界のインフルエンザ治療薬・ワクチン 売上予測2017-2028 - インフルエンザ治療薬・ワクチン の地域別販売量 - インフルエンザ治療薬・ワクチン の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別インフルエンザ治療薬・ワクチン 販売量 - 主要メーカー別インフルエンザ治療薬・ワクチン 売上 - 主要メーカー別インフルエンザ治療薬・ワクチン 価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（インフルエンザ治療薬、インフルエンザワクチン） - インフルエンザ治療薬・ワクチン の種類別販売量 - インフルエンザ治療薬・ワクチン の種類別売上 - インフルエンザ治療薬・ワクチン の種類別価格 ・用途別市場規模（病院薬局、小売店薬局、オンライン薬局） - インフルエンザ治療薬・ワクチン の用途別販売量 - インフルエンザ治療薬・ワクチン の用途別売上 - インフルエンザ治療薬・ワクチン の用途別価格 ・北米市場 - 北米のインフルエンザ治療薬・ワクチン 市場規模（種類別、用途別） - 主要国別のインフルエンザ治療薬・ワクチン 市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのインフルエンザ治療薬・ワクチン 市場規模（種類別、用途別） - 主要国別のインフルエンザ治療薬・ワクチン 市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のインフルエンザ治療薬・ワクチン 市場規模（種類別、用途別） - 主要国別のインフルエンザ治療薬・ワクチン 市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のインフルエンザ治療薬・ワクチン 市場規模（種類別、用途別） - 主要国別のインフルエンザ治療薬・ワクチン 市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのインフルエンザ治療薬・ワクチン 市場規模（種類別、用途別） - 主要国別のインフルエンザ治療薬・ワクチン 市場規模（トルコ、サウジアラビア） ・企業情報 Bristol Myers Squibb、AstraZeneca、Eli Lilly、Roche、GlaxoSmithKline、Novartis、Pfizer、Sanofi Pasteur、Bayer、Celgene、Seqirus、Protein Sciences Corporation、Serum Institute of India、Emergent Biosolutions、BioCryst Pharmaceuticals、Alvogen ・産業チェーン及び販売チャネル分析 - インフルエンザ治療薬・ワクチン の産業チェーン分析 - インフルエンザ治療薬・ワクチン の原材料 - インフルエンザ治療薬・ワクチン の生産プロセス - インフルエンザ治療薬・ワクチン の販売及びマーケティング - インフルエンザ治療薬・ワクチン の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - インフルエンザ治療薬・ワクチン の産業動向 - インフルエンザ治療薬・ワクチン のマーケットドライバー - インフルエンザ治療薬・ワクチン の課題 - インフルエンザ治療薬・ワクチン の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Influenza Drugs and Vaccines Market
Due to the COVID-19 pandemic, the global Influenza Drugs and Vaccines market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Influenza Drugs accounting for % of the Influenza Drugs and Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Influenza Drugs and Vaccines market size is valued at US$ million in 2021, while the US and Europe Influenza Drugs and Vaccines are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Influenza Drugs and Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Influenza Drugs and Vaccines include Bristol Myers Squibb, AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Influenza Drugs and Vaccines Scope and Segment
Influenza Drugs and Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Influenza Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Influenza Drugs
Influenza Vaccines
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Company
Bristol Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Influenza Drugs and Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Influenza Drugs
1.2.3 Influenza Vaccines
1.3 Market by Application
1.3.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Drugs and Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Influenza Drugs and Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Influenza Drugs and Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Influenza Drugs and Vaccines Sales by Region
2.4.1 Global Influenza Drugs and Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Influenza Drugs and Vaccines by Region (2023-2028)
2.5 Global Influenza Drugs and Vaccines Revenue by Region
2.5.1 Global Influenza Drugs and Vaccines Revenue by Region (2017-2022)
2.5.2 Global Influenza Drugs and Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Influenza Drugs and Vaccines Sales by Manufacturers
3.1.1 Global Top Influenza Drugs and Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza Drugs and Vaccines in 2021
3.2 Global Influenza Drugs and Vaccines Revenue by Manufacturers
3.2.1 Global Influenza Drugs and Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Drugs and Vaccines Revenue in 2021
3.3 Global Influenza Drugs and Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza Drugs and Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Drugs and Vaccines Sales by Type
4.1.1 Global Influenza Drugs and Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Influenza Drugs and Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Influenza Drugs and Vaccines Revenue by Type
4.2.1 Global Influenza Drugs and Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Influenza Drugs and Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Influenza Drugs and Vaccines Price by Type
4.3.1 Global Influenza Drugs and Vaccines Price by Type (2017-2022)
4.3.2 Global Influenza Drugs and Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Influenza Drugs and Vaccines Sales by Application
5.1.1 Global Influenza Drugs and Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Influenza Drugs and Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Influenza Drugs and Vaccines Revenue by Application
5.2.1 Global Influenza Drugs and Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Influenza Drugs and Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Influenza Drugs and Vaccines Price by Application
5.3.1 Global Influenza Drugs and Vaccines Price by Application (2017-2022)
5.3.2 Global Influenza Drugs and Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Influenza Drugs and Vaccines Market Size by Type
6.1.1 North America Influenza Drugs and Vaccines Sales by Type (2017-2028)
6.1.2 North America Influenza Drugs and Vaccines Revenue by Type (2017-2028)
6.2 North America Influenza Drugs and Vaccines Market Size by Application
6.2.1 North America Influenza Drugs and Vaccines Sales by Application (2017-2028)
6.2.2 North America Influenza Drugs and Vaccines Revenue by Application (2017-2028)
6.3 North America Influenza Drugs and Vaccines Market Size by Country
6.3.1 North America Influenza Drugs and Vaccines Sales by Country (2017-2028)
6.3.2 North America Influenza Drugs and Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Influenza Drugs and Vaccines Market Size by Type
7.1.1 Europe Influenza Drugs and Vaccines Sales by Type (2017-2028)
7.1.2 Europe Influenza Drugs and Vaccines Revenue by Type (2017-2028)
7.2 Europe Influenza Drugs and Vaccines Market Size by Application
7.2.1 Europe Influenza Drugs and Vaccines Sales by Application (2017-2028)
7.2.2 Europe Influenza Drugs and Vaccines Revenue by Application (2017-2028)
7.3 Europe Influenza Drugs and Vaccines Market Size by Country
7.3.1 Europe Influenza Drugs and Vaccines Sales by Country (2017-2028)
7.3.2 Europe Influenza Drugs and Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Influenza Drugs and Vaccines Market Size by Type
8.1.1 Asia Pacific Influenza Drugs and Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Influenza Drugs and Vaccines Market Size by Application
8.2.1 Asia Pacific Influenza Drugs and Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Influenza Drugs and Vaccines Market Size by Region
8.3.1 Asia Pacific Influenza Drugs and Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Influenza Drugs and Vaccines Market Size by Type
9.1.1 Latin America Influenza Drugs and Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Influenza Drugs and Vaccines Revenue by Type (2017-2028)
9.2 Latin America Influenza Drugs and Vaccines Market Size by Application
9.2.1 Latin America Influenza Drugs and Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Influenza Drugs and Vaccines Revenue by Application (2017-2028)
9.3 Latin America Influenza Drugs and Vaccines Market Size by Country
9.3.1 Latin America Influenza Drugs and Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Influenza Drugs and Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Influenza Drugs and Vaccines Market Size by Type
10.1.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Influenza Drugs and Vaccines Market Size by Application
10.2.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Influenza Drugs and Vaccines Market Size by Country
10.3.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Corporation Information
11.1.2 Bristol Myers Squibb Overview
11.1.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol Myers Squibb Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Overview
11.4.3 Roche Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Roche Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Corporation Information
11.8.2 Sanofi Pasteur Overview
11.8.3 Sanofi Pasteur Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Pasteur Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Pasteur Recent Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Overview
11.9.3 Bayer Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bayer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 Celgene
11.10.1 Celgene Corporation Information
11.10.2 Celgene Overview
11.10.3 Celgene Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Celgene Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Celgene Recent Developments
11.11 Seqirus
11.11.1 Seqirus Corporation Information
11.11.2 Seqirus Overview
11.11.3 Seqirus Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Seqirus Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Seqirus Recent Developments
11.12 Protein Sciences Corporation
11.12.1 Protein Sciences Corporation Corporation Information
11.12.2 Protein Sciences Corporation Overview
11.12.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Protein Sciences Corporation Recent Developments
11.13 Serum Institute of India
11.13.1 Serum Institute of India Corporation Information
11.13.2 Serum Institute of India Overview
11.13.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Serum Institute of India Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Serum Institute of India Recent Developments
11.14 Emergent Biosolutions
11.14.1 Emergent Biosolutions Corporation Information
11.14.2 Emergent Biosolutions Overview
11.14.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Emergent Biosolutions Recent Developments
11.15 BioCryst Pharmaceuticals
11.15.1 BioCryst Pharmaceuticals Corporation Information
11.15.2 BioCryst Pharmaceuticals Overview
11.15.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 BioCryst Pharmaceuticals Recent Developments
11.16 Alvogen
11.16.1 Alvogen Corporation Information
11.16.2 Alvogen Overview
11.16.3 Alvogen Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Alvogen Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alvogen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Influenza Drugs and Vaccines Industry Chain Analysis
12.2 Influenza Drugs and Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Drugs and Vaccines Production Mode & Process
12.4 Influenza Drugs and Vaccines Sales and Marketing
12.4.1 Influenza Drugs and Vaccines Sales Channels
12.4.2 Influenza Drugs and Vaccines Distributors
12.5 Influenza Drugs and Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Influenza Drugs and Vaccines Industry Trends
13.2 Influenza Drugs and Vaccines Market Drivers
13.3 Influenza Drugs and Vaccines Market Challenges
13.4 Influenza Drugs and Vaccines Market Restraints
14 Key Findings in The Global Influenza Drugs and Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Influenza Drugs and Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Influenza Drugs
Table 3. Major Manufacturers of Influenza Vaccines
Table 4. Global Influenza Drugs and Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Influenza Drugs and Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Influenza Drugs and Vaccines Sales by Region (2017-2022) & (MT)
Table 7. Global Influenza Drugs and Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Influenza Drugs and Vaccines Sales by Region (2023-2028) & (MT)
Table 9. Global Influenza Drugs and Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Influenza Drugs and Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Influenza Drugs and Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Influenza Drugs and Vaccines Sales by Manufacturers (2017-2022) & (MT)
Table 15. Global Influenza Drugs and Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Influenza Drugs and Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Influenza Drugs and Vaccines Price by Manufacturers (2017-2022) &(USD/Kg)
Table 19. Global Influenza Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs and Vaccines as of 2021)
Table 21. Influenza Drugs and Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Influenza Drugs and Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Influenza Drugs and Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 26. Global Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 27. Global Influenza Drugs and Vaccines Sales Share by Type (2017-2022)
Table 28. Global Influenza Drugs and Vaccines Sales Share by Type (2023-2028)
Table 29. Global Influenza Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Influenza Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Influenza Drugs and Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Influenza Drugs and Vaccines Revenue Share by Type (2023-2028)
Table 33. Influenza Drugs and Vaccines Price by Type (2017-2022) & (USD/Kg)
Table 34. Global Influenza Drugs and Vaccines Price Forecast by Type (2023-2028) & (USD/Kg)
Table 35. Global Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 36. Global Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 37. Global Influenza Drugs and Vaccines Sales Share by Application (2017-2022)
Table 38. Global Influenza Drugs and Vaccines Sales Share by Application (2023-2028)
Table 39. Global Influenza Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Influenza Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Influenza Drugs and Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Influenza Drugs and Vaccines Revenue Share by Application (2023-2028)
Table 43. Influenza Drugs and Vaccines Price by Application (2017-2022) & (USD/Kg)
Table 44. Global Influenza Drugs and Vaccines Price Forecast by Application (2023-2028) & (USD/Kg)
Table 45. North America Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 46. North America Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 47. North America Influenza Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Influenza Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 50. North America Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 51. North America Influenza Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Influenza Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)
Table 54. North America Influenza Drugs and Vaccines Sales by Country (2023-2028) & (MT)
Table 55. North America Influenza Drugs and Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Influenza Drugs and Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 58. Europe Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 59. Europe Influenza Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Influenza Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 62. Europe Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 63. Europe Influenza Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Influenza Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)
Table 66. Europe Influenza Drugs and Vaccines Sales by Country (2023-2028) & (MT)
Table 67. Europe Influenza Drugs and Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Influenza Drugs and Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 70. Asia Pacific Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 71. Asia Pacific Influenza Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Influenza Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 74. Asia Pacific Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 75. Asia Pacific Influenza Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Influenza Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2017-2022) & (MT)
Table 78. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2023-2028) & (MT)
Table 79. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 82. Latin America Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 83. Latin America Influenza Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Influenza Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 86. Latin America Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 87. Latin America Influenza Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Influenza Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)
Table 90. Latin America Influenza Drugs and Vaccines Sales by Country (2023-2028) & (MT)
Table 91. Latin America Influenza Drugs and Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Influenza Drugs and Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 94. Middle East and Africa Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 95. Middle East and Africa Influenza Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Influenza Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 98. Middle East and Africa Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 99. Middle East and Africa Influenza Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Influenza Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)
Table 102. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2023-2028) & (MT)
Table 103. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. Bristol Myers Squibb Corporation Information
Table 106. Bristol Myers Squibb Description and Major Businesses
Table 107. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 108. Bristol Myers Squibb Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Bristol Myers Squibb Recent Developments
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Major Businesses
Table 112. AstraZeneca Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 113. AstraZeneca Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. AstraZeneca Recent Developments
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Major Businesses
Table 117. Eli Lilly Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 118. Eli Lilly Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Eli Lilly Recent Developments
Table 120. Roche Corporation Information
Table 121. Roche Description and Major Businesses
Table 122. Roche Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 123. Roche Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Roche Recent Developments
Table 125. GlaxoSmithKline Corporation Information
Table 126. GlaxoSmithKline Description and Major Businesses
Table 127. GlaxoSmithKline Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 128. GlaxoSmithKline Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. GlaxoSmithKline Recent Developments
Table 130. Novartis Corporation Information
Table 131. Novartis Description and Major Businesses
Table 132. Novartis Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 133. Novartis Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Novartis Recent Developments
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Major Businesses
Table 137. Pfizer Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 138. Pfizer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Pfizer Recent Developments
Table 140. Sanofi Pasteur Corporation Information
Table 141. Sanofi Pasteur Description and Major Businesses
Table 142. Sanofi Pasteur Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 143. Sanofi Pasteur Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Sanofi Pasteur Recent Developments
Table 145. Bayer Corporation Information
Table 146. Bayer Description and Major Businesses
Table 147. Bayer Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 148. Bayer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Bayer Recent Developments
Table 150. Celgene Corporation Information
Table 151. Celgene Description and Major Businesses
Table 152. Celgene Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 153. Celgene Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Celgene Recent Developments
Table 155. Seqirus Corporation Information
Table 156. Seqirus Description and Major Businesses
Table 157. Seqirus Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 158. Seqirus Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Seqirus Recent Developments
Table 160. Protein Sciences Corporation Corporation Information
Table 161. Protein Sciences Corporation Description and Major Businesses
Table 162. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 163. Protein Sciences Corporation Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Protein Sciences Corporation Recent Developments
Table 165. Serum Institute of India Corporation Information
Table 166. Serum Institute of India Description and Major Businesses
Table 167. Serum Institute of India Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 168. Serum Institute of India Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Serum Institute of India Recent Developments
Table 170. Emergent Biosolutions Corporation Information
Table 171. Emergent Biosolutions Description and Major Businesses
Table 172. Emergent Biosolutions Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 173. Emergent Biosolutions Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Emergent Biosolutions Recent Developments
Table 175. BioCryst Pharmaceuticals Corporation Information
Table 176. BioCryst Pharmaceuticals Description and Major Businesses
Table 177. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 178. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. BioCryst Pharmaceuticals Recent Developments
Table 180. Alvogen Corporation Information
Table 181. Alvogen Description and Major Businesses
Table 182. Alvogen Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 183. Alvogen Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Alvogen Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Influenza Drugs and Vaccines Distributors List
Table 188. Influenza Drugs and Vaccines Customers List
Table 189. Influenza Drugs and Vaccines Market Trends
Table 190. Influenza Drugs and Vaccines Market Drivers
Table 191. Influenza Drugs and Vaccines Market Challenges
Table 192. Influenza Drugs and Vaccines Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs and Vaccines Product Picture
Figure 3. Global Influenza Drugs and Vaccines Market Share by Type in 2021 & 2028
Figure 3. Influenza Drugs Product Picture
Figure 4. Influenza Vaccines Product Picture
Figure 5. Global Influenza Drugs and Vaccines Market Share by Application in 2021 & 2028
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Influenza Drugs and Vaccines Report Years Considered
Figure 10. Global Influenza Drugs and Vaccines Sales 2017-2028 (MT)
Figure 11. Global Influenza Drugs and Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Influenza Drugs and Vaccines Revenue 2017-2028 (US$ Million)
Figure 13. Global Influenza Drugs and Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Influenza Drugs and Vaccines Sales Market Share by Region (2017-2022)
Figure 15. Global Influenza Drugs and Vaccines Sales Market Share by Region (2023-2028)
Figure 16. North America Influenza Drugs and Vaccines Sales YoY (2017-2028) & (MT)
Figure 17. North America Influenza Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Influenza Drugs and Vaccines Sales YoY (2017-2028) & (MT)
Figure 19. Europe Influenza Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Influenza Drugs and Vaccines Sales YoY (2017-2028) & (MT)
Figure 21. Asia-Pacific Influenza Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Influenza Drugs and Vaccines Sales YoY (2017-2028) & (MT)
Figure 23. Latin America Influenza Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Influenza Drugs and Vaccines Sales YoY (2017-2028) & (MT)
Figure 25. Middle East & Africa Influenza Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Influenza Drugs and Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Influenza Drugs and Vaccines in the World: Market Share by Influenza Drugs and Vaccines Revenue in 2021
Figure 28. Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 30. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2028)
Figure 31. Global Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 32. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2028)
Figure 33. North America Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 34. North America Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2028)
Figure 35. North America Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 36. North America Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2028)
Figure 37. North America Influenza Drugs and Vaccines Sales Share by Country (2017-2028)
Figure 38. North America Influenza Drugs and Vaccines Revenue Share by Country (2017-2028)
Figure 39. U.S. Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 42. Europe Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2028)
Figure 43. Europe Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 44. Europe Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2028)
Figure 45. Europe Influenza Drugs and Vaccines Sales Share by Country (2017-2028)
Figure 46. Europe Influenza Drugs and Vaccines Revenue Share by Country (2017-2028)
Figure 47. Germany Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 48. France Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Influenza Drugs and Vaccines Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Influenza Drugs and Vaccines Revenue Share by Region (2017-2028)
Figure 58. China Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. India Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Latin America Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 71. Latin America Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Influenza Drugs and Vaccines Sales Share by Country (2017-2028)
Figure 73. Latin America Influenza Drugs and Vaccines Revenue Share by Country (2017-2028)
Figure 74. Mexico Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Influenza Drugs and Vaccines Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Influenza Drugs and Vaccines Revenue Share by Country (2017-2028)
Figure 83. Turkey Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Influenza Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
Figure 86. Influenza Drugs and Vaccines Value Chain
Figure 87. Influenza Drugs and Vaccines Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed